HealthcareServices

Multiomics Market Size and Demand Forecast 2026–2030

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the multiomics market from 2026–2035 with trusted insights from The Business Research Company

How much is the Multiomics Market valued at in 2026, and what valuation is forecast for 2030?

The multiomics market has experienced substantial growth in recent years. Its value is expected to rise from $3.85 billion in 2025 to $4.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 17.6%. This historical expansion can be attributed to several factors, including the increasing adoption of genomic sequencing, the early development of transcriptomics tools, greater accessibility of proteomic analysis platforms, the expansion of research into biomarker identification, and the rise in biological data generation.

The multiomics market is projected to experience substantial growth over the next few years, with its valuation expected to climb to $8.07 billion by 2030, reflecting a compound annual growth rate (CAGR) of 15.6%. This expansion throughout the forecast period is driven by factors such as advancements in multiomics platforms, an increasing demand for personalized medicine, the enhanced integration of AI-based analytics, the escalating utilization of metabolomics in clinical settings, and the broadening application of multiomics in precision agriculture. Significant trends for the forecast period include the increasing adoption of single-cell multiomics, the rising integration of multi-layer biological data, an expanded use of multiomics in early disease diagnostics, its expansion within drug discovery pipelines, and its growing application in agricultural genomics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Drivers Are Influencing The Growth Of The Multiomics Market?

The increasing need for individualized medicine is anticipated to drive the expansion of the multiomics market in the future. Individualized medicine is defined as a healthcare strategy that tailors medical choices and interventions for each patient, considering their unique genetic makeup, environmental influences, and lifestyle habits. The adoption of this individualized medical strategy is expanding because of breakthroughs in technology, a growing requirement for specific treatments, and enhancements across global healthcare systems. Multiomics supports individualized medicine by offering an in-depth insight into a person’s genetic, molecular, and metabolic data, allowing medical professionals to customize therapies according to each patient’s distinct features. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a rise from 6 approvals in 2022. Consequently, the growing demand for individualized medicine is fueling the expansion of the multiomics market.

How Is The Multiomics Market Organized Into Various Segments?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

What Trends Are Reshaping The Dynamics Of The Multiomics Market?

Major companies within the multiomics market are developing advanced single-cell multiomics platforms, enabling scientists to conduct large-scale studies without compromising sample integrity. These platforms integrate diverse omics with artificial intelligence capabilities, allowing users to seamlessly analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For instance, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, introduced the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system allows scientists to isolate, barcode, and analyze single cells with high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, offering the flexibility to simultaneously analyze multiple samples and different cell sizes and types, such as stem cells or cancer cells, thereby enhancing researchers’ ability to gain more insights in less time.

Who Are The Core Companies Influencing Trends In The Multiomics Market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Region Is Projected To Lead The Multiomics Market During The Forecast Period?

North America was the largest region in the multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Multiomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Browse Through More Reports Similar to the Global Multiomics Market 2026, By The Business Research Company

Computational Biology Market Report 2026

https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Bioinformatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795